FDA Approval of Pimavanserin: Response to Absence of Evidence Versus Evidence of Absence-Pimavanserin and the SAPS-PD.
Schubmehl S, Sussman J. FDA Approval of Pimavanserin: Response to Absence of Evidence Versus Evidence of Absence-Pimavanserin and the SAPS-PD. Am J Geriatr Psychiatry. 2018 10; 26(10):1014.